Benign Prostatic Hyperplasia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Benign Prostatic Hyperplasia stocks.

Benign Prostatic Hyperplasia Stocks Recent News

Date Stock Title
May 15 LLY Dow Jones Futures: Dow, S&P 500, Nasdaq Hit Highs, Nvidia Leads 12 New Buys; What To Do Now
May 15 BSX Centene (CNC) to Continue Serving Kansas' Medicaid Members
May 15 BSX Boston Scientific recalls more than 1M angiographic catheters
May 15 LLY Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
May 15 BSX Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
May 15 BSX GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy
May 15 LLY Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
May 15 LLY Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
May 15 LLY UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
May 15 LLY Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
May 15 BSX 3 Solid Buys From MedTech Following 2024 Guidance Raise
May 15 BSX Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year?
May 15 BSX Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
May 15 VERU Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
May 15 LLY Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
May 15 LLY These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
May 14 LLY Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
May 14 LLY Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
May 14 BSX Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts
May 14 BSX Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.The cause is unclear. Risk factors include a family history, obesity, type 2 diabetes, not enough exercise, and erectile dysfunction. Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms. The underlying mechanism involves the prostate pressing on the urethra thereby making it difficult to pass urine out of the bladder. Diagnosis is typically based on symptoms and examination after ruling out other possible causes.Treatment options including lifestyle changes, medications, a number of procedures, and surgery. In those with mild symptoms weight loss, exercise, and decreasing caffeine intake is recommended. In those with more significant symptoms medications may include alpha blockers such as terazosin or 5α-reductase inhibitors such as finasteride. Surgical removal of part of the prostate may be carried out in those who do not improve with other measures. Alternative medicine, such as saw palmetto, does not appear to help.About 105 million people are affected globally. BPH typically begins after the age of 40. Half of males age 50 and over are affected. After the age of 80 about 90% of males are affected. Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer.

Browse All Tags